Effects of Oral Tranexamic Acid on Short Term Postoperative Outcomes Following Total Shoulder Arthroplasty

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
University of Alabama at Birmingham
Study ID
NCT06902714
Phase
PHASE3
Status
Recruiting
Apply to this trial

Conditions

  • Shoulder Arthroplasty

Eligibility Criteria

Sex
ALL
Age
18 Years - 79 Years
Healthy Volunteers
Not accepted

Interventions

  • oral tranexamic acid — DRUG
    one group of subjects will receive oral tranexamic acid and the other will receive oral placebo
  • Placebo — DRUG
    one group of randomized subjects will receive placebo and the other will receive oral tranexamic acid

Study Details

The purpose of this clinical trial is to evaluate the short-term clinical outcomes of patients undergoing total shoulder arthroplasty who receive an extended postoperative course of oral tranexamic acid

Key Dates

Start date
Apr 20, 2026
Status verified
Apr 2026
Primary completion
Jul 31, 2028
Completion
Dec 31, 2030

Study Design

Enrollment
60 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: oral tranexamic acid
  • Placebo Comparator: Oral Placebo

Primary Outcome Measure

VAS [ Time Frame: 2 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Alabama at BirminghamBirminghamAlabama35205
Walter Smith
[email protected]
205-930-8554
Walter Smith, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Birmingham, AL

By research site
University of Alabama at Birmingham· Birmingham, AL

Related Studies